Cumberland Pharmaceuticals Company Profile (NASDAQ:CPIX)

About Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals logoCumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Symbol: NASDAQ:CPIX
  • CUSIP: 23077010
  • Web: www.cumberlandpharma.com
Capitalization:
  • Market Cap: $112.57 million
  • Outstanding Shares: 16,013,000
Average Prices:
  • 50 Day Moving Avg: $6.30
  • 200 Day Moving Avg: $5.95
  • 52 Week Range: $4.40 - $7.48
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 78.11
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $33.03 million
  • Price / Sales: 3.41
  • Book Value: $4.56 per share
  • Price / Book: 1.54
Profitability:
  • EBIDTA: $963,777.00
  • Net Margins: -0.14%
  • Return on Equity: 1.46%
  • Return on Assets: 1.22%
Debt:
  • Debt-to-Equity Ratio: 0.05%
  • Current Ratio: 5.73%
  • Quick Ratio: 5.31%
Misc:
  • Average Volume: 26,105 shs.
  • Beta: 1.36
  • Short Ratio: 2.39
 

Frequently Asked Questions for Cumberland Pharmaceuticals (NASDAQ:CPIX)

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) released its earnings results on Monday, May, 15th. The company reported ($0.08) EPS for the quarter. The company had revenue of $9.64 million for the quarter. Cumberland Pharmaceuticals had a negative net margin of 0.14% and a positive return on equity of 1.46%. View Cumberland Pharmaceuticals' Earnings History.

Are investors shorting Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals saw a increase in short interest in the month of April. As of April 13th, there was short interest totalling 91,490 shares, an increase of 26.3% from the March 31st total of 72,452 shares. Based on an average trading volume of 5,786 shares, the short-interest ratio is currently 15.8 days.

Who are some of Cumberland Pharmaceuticals' key competitors?

Who owns Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Ariel Investments LLC (8.70%), Dimensional Fund Advisors LP (5.39%), Stonepine Capital Management LLC (4.62%), Vanguard Group Inc. (1.86%), Renaissance Technologies LLC (1.69%) and Acadian Asset Management LLC (0.81%). Company insiders that own Cumberland Pharmaceuticals stock include Michael Bonner and Thomas R Lawrence. View Institutional Ownership Trends for Cumberland Pharmaceuticals.

Who sold Cumberland Pharmaceuticals stock? Who is selling Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including Ariel Investments LLC and Bard Associates Inc.. View Insider Buying and Selling for Cumberland Pharmaceuticals.

Who bought Cumberland Pharmaceuticals stock? Who is buying Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Ameriprise Financial Inc., Renaissance Technologies LLC, Dimensional Fund Advisors LP, Acadian Asset Management LLC, Geode Capital Management LLC and Morgan Stanley. View Insider Buying and Selling for Cumberland Pharmaceuticals.

How do I buy Cumberland Pharmaceuticals stock?

Shares of Cumberland Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cumberland Pharmaceuticals stock cost?

One share of Cumberland Pharmaceuticals stock can currently be purchased for approximately $7.03.

Analyst Ratings

Consensus Ratings for Cumberland Pharmaceuticals (NASDAQ:CPIX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Earnings by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Earnings History by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/2017Q1 2017($0.08)$9.64 millionViewN/AView Earnings Details
3/7/2017Q4 2016$0.05$9.08 millionViewListenView Earnings Details
11/1/2016Q316$0.01$7.90 million$8.80 millionViewN/AView Earnings Details
5/10/2016Q116$0.02$8.70 million$7.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$8.10 million$8.70 millionViewN/AView Earnings Details
5/13/2014Q114$0.02$10.26 million$8.09 millionViewN/AView Earnings Details
3/4/2014Q4 13$0.05($0.08)ViewN/AView Earnings Details
11/5/2013Q313($0.04)$7.60 million$6.50 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.02($0.03)$9.40 million$7.10 millionViewN/AView Earnings Details
5/2/2013Q113$0.05$0.05$10.00 million$10.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$0.14$0.09$13.87 million$13.70 millionViewN/AView Earnings Details
11/1/2012Q312$0.09$0.10$13.05 million$12.50 millionViewN/AView Earnings Details
8/2/2012$0.07$0.09ViewN/AView Earnings Details
5/3/2012$0.05$0.02ViewN/AView Earnings Details
2/29/2012$0.05$0.04ViewN/AView Earnings Details
11/3/2011$0.06$0.09ViewN/AView Earnings Details
8/4/2011$0.04$0.11ViewN/AView Earnings Details
5/5/2011$0.03$0.03ViewN/AView Earnings Details
3/8/2011$0.03$0.04ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Current Year EPS Consensus Estimate: $0.09 EPS
Next Year EPS Consensus Estimate: $0.09 EPS

Dividends

Dividend History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Insider Ownership Percentage: 37.00%
Institutional Ownership Percentage: 34.17%
Insider Trades by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Institutional Ownership by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Insider Trades by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/7/2017Thomas R. LawrenceDirectorSell6,000$6.40$38,400.00View SEC Filing  
3/23/2017Michael BonnerCFOBuy900$6.42$5,778.00View SEC Filing  
11/17/2016Michael BonnerCFOBuy900$5.50$4,950.00View SEC Filing  
8/17/2016Thomas R LawrenceDirectorSell3,000$4.60$13,800.00View SEC Filing  
5/26/2016Thomas R LawrenceDirectorSell3,000$4.55$13,650.00View SEC Filing  
11/19/2015Thomas R LawrenceDirectorSell4,000$5.61$22,440.00View SEC Filing  
3/19/2015Thomas R LawrenceDirectorSell6,000$6.95$41,700.00View SEC Filing  
11/20/2014Thomas R LawrenceDirectorSell10,000$5.12$51,200.00View SEC Filing  
8/21/2014Thomas R LawrenceDirectorSell15,000$5.08$76,200.00View SEC Filing  
3/19/2014Thomas LawrenceDirectorSell20,000$4.54$90,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Latest Headlines for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Source:
DateHeadline
finance.yahoo.com logoCumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 4:18 PM
americanbankingnews.com logoCumberland Pharmaceuticals, Inc. (CPIX) Announces Quarterly Earnings Results
www.americanbankingnews.com - May 16 at 2:20 PM
finance.yahoo.com logoEdited Transcript of CPIX earnings conference call or presentation 15-May-17 8:30pm GMT
finance.yahoo.com - May 16 at 12:16 PM
finance.yahoo.com logoInvestor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call
finance.yahoo.com - May 15 at 4:23 PM
finance.yahoo.com logoInvestor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call
finance.yahoo.com - May 15 at 4:23 PM
finance.yahoo.com logoCumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017
finance.yahoo.com - May 15 at 4:23 PM
finance.yahoo.com logoCumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017
finance.yahoo.com - May 15 at 4:23 PM
finance.yahoo.com logoCumberland Pharmaceuticals to Announce First Quarter 2017 Financial Results
finance.yahoo.com - May 8 at 4:21 PM
americanbankingnews.com logoCumberland Pharmaceuticals (CPIX) Getting Somewhat Positive News Coverage, AlphaOne Reports
www.americanbankingnews.com - May 1 at 6:28 PM
americanbankingnews.com logoCumberland Pharmaceuticals, Inc. (CPIX) Short Interest Up 26.3% in April
www.americanbankingnews.com - April 29 at 11:56 PM
americanbankingnews.com logoCumberland Pharmaceuticals (CPIX) Given Daily Media Sentiment Rating of 0.36
www.americanbankingnews.com - April 27 at 10:30 AM
finance.yahoo.com logoNew Kristalose® Growth Driver Established Through Co-Promotion Agreement
finance.yahoo.com - April 26 at 5:52 PM
americanbankingnews.com logoCumberland Pharmaceuticals (CPIX) Getting Somewhat Positive Press Coverage, AlphaOne Reports
www.americanbankingnews.com - April 23 at 5:06 PM
americanbankingnews.com logoThomas R. Lawrence Sells 6,000 Shares of Cumberland Pharmaceuticals, Inc. (CPIX) Stock
www.americanbankingnews.com - April 7 at 8:28 PM
streetinsider.com logoCumberland Pharmaceuticals (CPIX) Reports Significant Post Surgical Pain Reduction and Decrease in Opioid Use from Caldolor®
www.streetinsider.com - March 28 at 4:14 PM
finance.yahoo.com logoCaldolor® Demonstrates Significant Post Surgical Pain Reduction and Decrease in Opioid Use
finance.yahoo.com - March 27 at 4:22 PM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Stateme
biz.yahoo.com - March 22 at 9:35 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc.
finance.yahoo.com - March 22 at 4:35 PM
businesswire.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland ...
www.businesswire.com - March 18 at 1:56 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc.
finance.yahoo.com - March 17 at 3:54 PM
finance.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Financials
finance.yahoo.com - March 16 at 5:49 PM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant
biz.yahoo.com - March 16 at 5:49 PM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 13 at 12:28 PM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - March 10 at 5:32 PM
finance.yahoo.com logoEdited Transcript of CPIX earnings conference call or presentation 7-Mar-17 9:30pm GMT
finance.yahoo.com - March 8 at 5:12 PM
finance.yahoo.com logoCumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results
finance.yahoo.com - March 7 at 4:26 PM
biz.yahoo.com logoQ4 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
biz.yahoo.com - March 7 at 12:16 PM
finance.yahoo.com logoCumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2016 Financial Results
finance.yahoo.com - February 28 at 4:39 PM
prnewswire.com logoCaldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics
www.prnewswire.com - February 7 at 5:35 PM
prnewswire.com logoCaldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics
www.prnewswire.com - February 7 at 5:35 PM
us.rd.yahoo.com logoU.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case
us.rd.yahoo.com - January 30 at 5:19 PM
us.rd.yahoo.com logo8:17 am Cumberland Pharma announces the U.S. Court of Appeals for the Federal Circuit ruled in favor of Cumberland in a patent case associated with its Acetadote product, rejecting Mylan's (MYL) challenge o
us.rd.yahoo.com - January 30 at 5:19 PM
finance.yahoo.com logoCumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
finance.yahoo.com - January 16 at 10:28 AM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
biz.yahoo.com - January 13 at 5:11 PM
streetinsider.com logoCumberland Pharmaceuticals (CPIX), Clinigen Enter Pact for Commercialization of Totect
www.streetinsider.com - January 9 at 10:37 PM
finance.yahoo.com logo9:31 am Cumberland Pharma and and Clinigen Group plc announce an exclusive agreement to commercialize the oncology support drug Totect (dexrazoxane hydrochloride) in the U.S.
finance.yahoo.com - January 9 at 5:37 PM
finance.yahoo.com logoBlog Coverage Cumberland Pharma Bags Exclusive Rights for Europe Based Nordic Group Injectable Methotrexate Product Line for the US Market
finance.yahoo.com - November 17 at 10:16 AM
finance.yahoo.com logoEdited Transcript of CPIX earnings conference call or presentation 1-Nov-16 8:30pm GMT
finance.yahoo.com - November 2 at 4:27 PM
biz.yahoo.com logoQ3 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
biz.yahoo.com - November 1 at 8:33 AM
finance.yahoo.com logoCumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com November 3
finance.yahoo.com - October 28 at 4:04 PM
streetinsider.com logoCumberland Pharmaceuticals (CPIX) Commences Shipments of Ethyol to U.S. Wholesalers
www.streetinsider.com - August 24 at 9:37 AM
biz.yahoo.com logoQ2 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
biz.yahoo.com - August 2 at 9:12 AM
finance.yahoo.com logoCumberland Pharmaceuticals To Participate In Avondale Partners' 4th Annual Healthcare Conference
finance.yahoo.com - July 18 at 9:00 AM
finance.yahoo.com logoEdited Transcript of CPIX earnings conference call or presentation 10-May-16 8:30pm GMT
finance.yahoo.com - May 10 at 6:33 PM
biz.yahoo.com logoQ1 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
biz.yahoo.com - May 10 at 7:07 AM

Social

Chart

Cumberland Pharmaceuticals (CPIX) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff